{"id":"NCT00862251","sponsor":"Organon and Co","briefTitle":"Ezetimibe/Simvastatin (MK-0653A) Versus Rosuvastatin Versus Doubling Statin Dose in Participants With Cardiovascular Disease and Diabetes Mellitus (MK-0653A-133)(COMPLETED)","officialTitle":"A Randomized, Double-Blind, Active-Controlled Study of Patients With Cardiovascular Disease and Diabetes Mellitus Not Adequately Controlled With Simvastatin or Atorvastatin: Comparison of Switching to Combination Tablet Ezetimibe/Simvastatin Versus Switching to Rosuvastatin or Doubling the Statin Dose","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-04","primaryCompletion":"2011-03","completion":"2011-03","firstPosted":"2009-03-16","resultsPosted":"2012-03-16","lastUpdate":"2024-05-16"},"enrollment":808,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Cardiovascular Disorder","Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"ezetimibe (+) simvastatin","otherNames":["Vytorin"]},{"type":"DRUG","name":"simvastatin 40 mg or atorvastatin 20 mg","otherNames":["Lipitor, Zocor"]},{"type":"DRUG","name":"Rosuvastatin","otherNames":["Crestor"]},{"type":"DRUG","name":"atorvastatin 10 mg or simvastatin 20 mg","otherNames":["Lipitor, Zocor"]}],"arms":[{"label":"Ezetimibe/simvastatin","type":"EXPERIMENTAL"},{"label":"Doubling statin dose","type":"ACTIVE_COMPARATOR"},{"label":"Rosuvastatin","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to determine the efficacy of switching to a combination tablet ezetimibe/simvastatin (10mg/20mg) versus rosuvastatin (10 mg) versus doubling the statin dose in those patients who have cardiovascular disease and diabetes mellitus not adequately controlled on simvastatin 20 mg or atorvastatin 10 mg.","primaryOutcome":{"measure":"Percent Change From Baseline in Low-density Lipoprotein Cholesterol (LDL-C) After Switching to Treatment With Ezetimibe/Simvastatin vs Doubling the Dose of Statin (Simvastatin or Atorvastatin).","timeFrame":"Baseline and Week 6","effectByArm":[{"arm":"Ezetimibe/Simvastatin","deltaMin":-23.13,"sd":null},{"arm":"Doubling Statin Dose","deltaMin":-8.37,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":16},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["26486166","23866306","23288881","23279632"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":321},"commonTop":[]}}